A randomized, open-label, crossover study assessing the pharmacokinetic and pharmacodynamic bioequivalence of pegfilgrastim-cbqv via on-body injector vs prefilled syringe.

Hong Tang, Barbara Finck, Hillary O’Kelly et al.|Journal of Clinical Oncology|2022

Cited by 1